Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Angiodynamics (ANGO) Short-term Investments (2016 - 2018)

Angiodynamics (ANGO) has disclosed Short-term Investments for 8 consecutive years, with $1.3 million as the latest value for Q4 2018.

  • For the quarter ending Q4 2018, Short-term Investments rose 7.14% year-over-year to $1.3 million, compared with a TTM value of $1.3 million through Nov 2018, up 7.14%, and an annual FY2018 reading of $1.3 million, up 8.4% over the prior year.
  • Short-term Investments was $1.3 million for Q4 2018 at Angiodynamics, roughly flat from $1.3 million in the prior quarter.
  • Across five years, Short-term Investments topped out at $1.8 million in Q2 2014 and bottomed at $1.2 million in Q4 2016.
  • Average Short-term Investments over 5 years is $1.5 million, with a median of $1.6 million recorded in 2015.
  • The sharpest move saw Short-term Investments fell 27.79% in 2017, then increased 11.11% in 2018.
  • Year by year, Short-term Investments stood at $1.7 million in 2014, then dropped by 3.47% to $1.6 million in 2015, then dropped by 26.6% to $1.2 million in 2016, then rose by 4.74% to $1.3 million in 2017, then grew by 7.14% to $1.3 million in 2018.
  • Business Quant data shows Short-term Investments for ANGO at $1.3 million in Q4 2018, $1.3 million in Q3 2018, and $1.3 million in Q2 2018.